What are the best medications for treating night terrors according to the American Academy of Sleep Medicine (AASM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Important Clarification: AASM Does Not Have Guidelines for Night Terrors Medications

The American Academy of Sleep Medicine (AASM) does not have published clinical practice guidelines specifically addressing pharmacologic treatment of night terrors (sleep terrors). The evidence provided consists entirely of AASM guidelines for nightmare disorder and insomnia, which are fundamentally different conditions from night terrors.

Critical Distinction

Night terrors are non-REM parasomnias occurring during deep sleep (stage 3-4 NREM), primarily affecting children, characterized by sudden arousal with screaming, autonomic hyperactivity, and amnesia for the event 1. In contrast, nightmares are REM sleep phenomena with dream recall, and the AASM guidelines address nightmare disorder (particularly PTSD-associated nightmares) 2.

What the Evidence Actually Shows

For Nightmare Disorder (NOT Night Terrors):

The AASM 2010 Best Practice Guide recommends:

  • Prazosin (Level A recommendation) for PTSD-associated nightmares at 1-10 mg at bedtime 2
  • Clonidine (Level C) may be considered at 0.2-0.6 mg divided doses 2
  • Various other agents (Level C) with sparse data 2

For Night Terrors Specifically:

Based on the limited research evidence available 1:

Medical intervention is usually not necessary for night terrors. When pharmacotherapy is considered for frequent, severe episodes causing functional impairment:

  • Clonazepam may be used short-term at bedtime (specific dosing not established in guidelines)
  • Anticipatory awakening (behavioral intervention) performed 30 minutes before typical episode timing is often effective 1

One case report mentions haloperidol and clonidine for atypical night terrors in a complex medical case 3, but this represents extremely limited evidence.

Clinical Approach for Night Terrors

Since AASM has no formal medication guidelines for night terrors, the evidence-based approach prioritizes:

  1. Reassurance and parental education - most children outgrow this by late adolescence 1
  2. Sleep hygiene optimization - adequate sleep duration prevents episodes 1
  3. Treat underlying conditions - sleep deprivation, sleep apnea, fever 1
  4. Safety measures - prevent injury during episodes
  5. Anticipatory awakening - for frequent, predictable episodes 1
  6. Pharmacotherapy (clonazepam) - reserved only for severe, frequent episodes with significant functional impairment 1

The question cannot be fully answered as asked because the AASM has not published medication guidelines for night terrors.

References

Research

Sleep Terrors: An Updated Review.

Current pediatric reviews, 2020

Guideline

best practice guide for the treatment of nightmare disorder in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Related Questions

How should night terrors (pavor nocturnus) in a 10‑month‑old infant be evaluated and managed?
What are night terrors (sleep terrors) and what is the recommended management in children?
What are the differential diagnoses for night terrors?
What is the best approach to address sleep association issues in a 2-year-old child who wakes up at midnight and requires parental presence to fall back asleep?
What is the most appropriate initial recommendation for a 7-year-old girl with difficulty falling asleep, variable bedtime, irregular sleep locations, occasional night waking, and frequent naps?
Can lamotrigine cause abnormal coagulation?
In a 43-year-old female with a two-year history of progressively enlarging brown macules on the cheeks and nasal bridge, without itching, pain, burning, fever, or other skin findings, and with minimal sun exposure while using daily sunscreen, what is the most likely diagnosis and recommended first-line therapy?
What are the recommended acute and preventive management strategies for juvenile recurrent parotitis in children aged 2–8 years?
For a COPD patient who normally receives low‑flow home oxygen (~1 L/min, roughly 24% fraction of inspired oxygen), should I set the fraction of inspired oxygen on the high‑flow nasal cannula (HFNC) by using a venturi set to 60% FiO₂ and adjusting a blender for the remaining oxygen, or should I set the FiO₂ directly on the HFNC device?
How should I interpret a sputum culture growing Corynebacterium and decide whether treatment is needed, including appropriate therapy if it is a true pathogen?
What is the recommended dosing regimen of methenamine hippurate for urinary tract infection prophylaxis in adults and children?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.